Cost-Effectiveness Analysis of Xpert MTB/RIF Ultra for the Diagnosis of HIV-Associated Tuberculous Meningitis.

Siddiqi OK, Jahn B, Rochau U, Walukaga S, Rajasingham R, Siebert U.

Open source

DOI
10.1093/cid/ciag348
Published
2026-09-01
Container
Clin Infect Dis
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciag348,
  title = {Cost-Effectiveness Analysis of Xpert MTB/RIF Ultra for the Diagnosis of HIV-Associated Tuberculous Meningitis.},
  author = {Siddiqi OK and  Jahn B and  Rochau U and  Walukaga S and  Rajasingham R and  Siebert U.},
  year = {2026},
  journal = {Clin Infect Dis},
  doi = {10.1093/cid/ciag348},
  url = {https://doi.org/10.1093/cid/ciag348}
}

RIS

TY  - JOUR
TI  - Cost-Effectiveness Analysis of Xpert MTB/RIF Ultra for the Diagnosis of HIV-Associated Tuberculous Meningitis.
AU  - Siddiqi OK
AU  -  Jahn B
AU  -  Rochau U
AU  -  Walukaga S
AU  -  Rajasingham R
AU  -  Siebert U.
PY  - 2026
JO  - Clin Infect Dis
DO  - 10.1093/cid/ciag348
UR  - https://doi.org/10.1093/cid/ciag348
ER  - 

APA

OK, S., B, J., U, R., S, W., R, R., & U., S. (2026). Cost-Effectiveness Analysis of Xpert MTB/RIF Ultra for the Diagnosis of HIV-Associated Tuberculous Meningitis.. Clin Infect Dis. https://doi.org/10.1093/cid/ciag348

Source records